A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors

Clinical trial NCT06771921 · TERMINATED

Trial details

NCT number: NCT06771921
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Solid Tumor

Start date: 2025-01-29
Primary completion: 2025-06-11
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.